{
    "nct_id": "NCT03419741",
    "official_title": "Repetitive Transcranial Magnetic Stimulation For Smoking Cessation In Cancer Patients",
    "inclusion_criteria": "* 1. Completed cancer treatment (e.g. surgery, chemotherapy and radiation) > 6 months Patients with current endocrine therapy will be included for the study.\n\n  2. Have been diagnosed with noninvasive or invasive (Stage 1, 2, or 3A) breast cancer or prostate cancer.\n\n  3. Smoke 5 or more cigarettes per day and have a carbon monoxide (CO) level > 5 ppm indicative of recent smoking.\n\n  4. Not have received substance abuse treatment within the previous 30 days. 5. Meet criteria for low to moderate nicotine dependence as determined by FTND â‰¥1.\n\n  6. Be willing to provide informed consent. 7. Be able to comply with protocol requirements and likely to complete all study procedures.\n\n  8. Is willing to consider trying to quit smoking. 9. Have no active cardiac, neurologic, or psychiatric illness. 10. 0.5-10 years post diagnosis of cancer at the time enrollment.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Current dependence, defined by Diagnostic and Statistical manual of Mental Disorders (DSM)-V criteria, on any psychoactive substances other than nicotine or caffeine.\n2. Contraindication to rTMS (history of neurological disorder or seizure, increased intracranial pressure, brain surgery, or head trauma with loss of consciousness for > 15 minutes, implanted electronic device, metal in the head, or pregnancy).\n3. History of autoimmune, endocrine, viral, or vascular disorder affecting the brain.\n4. History of neurological disorder that would lead to local or diffuse brain lesions or significant physical impairment.",
    "miscellaneous_criteria": ""
}